Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 17 Sep 2021 17:00
Last (SGD): 0.130 Change: -0.004 High: 0.132 Remarks: -
Change (%): -2.99 Low: 0.130
Open 0.132 Yesterday's Close 0.134
Buy Price 0.130 Sell Price 0.132
Buy Volume ('000) 60.3 Sell Volume ('000) 103.4
Cumulative Volume ('000) 493.6 Cumulative Value 64,967
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01752 Trailing EPS (SGD) e -0.02843 NAV (SGD) b 0.0199
PE a - Trailing PE f - Price / NAV b 6.5327
Dividend (SGD) d - Cash In Hand (SGD) g 0.0289 Issued & Paid-up Shares c 265,452,000
Dividend Yield (%) d - Price / Cash In Hand g 4.498 Treasury Shares h -
Beta - 75 Daysi 0.826 R-Squared - 75 Days(%)i 1.29 Market Cap (M) 34.509
Beta - 500 Daysi 0.336 R-Squared - 500 Days (%)i 0.49 Enterprise Value (M) 31.612
Piotroski F Score 2 Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 66.9017 6-Month VWAP 0.255 Free Float (%) 34.3
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Prof, Scientific & Technical Activities - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 19 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 34.509 - - 6.5327 -
Industry Medical & Biotechnology SGX 1,011.553 18.759 15.992 1.4250 3.010
Medical Specialties SGX 1,424.429 9.672 2.818 3.1885 4.132
Index FTSE ST Catalist Index SGX 61.407 33.240 24.361 1.3833 1.846
Local Peer Top Glove SGX 7,967.034 13.121 2.854 3.6235 3.930
Local Peer UGHealthcare SGX 249.585 2.101 2.102 1.3094 1.262
Local Peer Medtecs Intl SGX 232.225 1.334 1.595 0.9251 15.876
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 234,792.459 36.830 27.314 6.3709 0.149
Global Peer DANAHER CORP NYSE 231,681.967 66.006 66.006 5.8671 0.221
Global Peer ABBOTT LABORATORIES NYSE 224,775.848 50.252 35.420 6.6502 1.206
Global Peer MEDTRONIC PLC NYSE 174,551.557 48.406 44.953 3.3903 1.865
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,425.795 116.374 76.067 11.3888 -
Global Peer STRYKER CORP NYSE 102,958.521 64.389 49.428 7.4500 0.860
Global Peer BECTON DICKINSON & CO NYSE 75,229.420 98.083 40.337 3.1173 1.234
Global Peer EDWARDS LIFESCIENCES CORP NYSE 74,437.830 90.403 50.901 14.5010 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,176.224 - 134.992 3.9629 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 56,839.293 32.006 81.379 16.7944 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), ANGELALIGN (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), TOPGLOV (Bursa), INMODE LTD (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), BUTTERFLY NETWORK INC (NYSE), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), ZYLOXTB-B (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), KANGJI MEDICAL (HKEx), MESA LABORATORIES INC (NASDAQ), SUPERMX (Bursa), AVANOS MEDICAL INC (NYSE), TREACE MED CONCEPTS INC (NASDAQ), AK MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), DERMTECH INC (NASDAQ), VIEWRAY INC (NASDAQ), 908 DEVICES INC (NASDAQ), MODERN DENTAL (HKEx), ANGIODYNAMICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CRYOLIFE INC (NYSE), CIRC (HKEx), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), CUTERA INC (NASDAQ), SISRAM MED (HKEx), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), BIOVENTUS INC (NASDAQ), NYXOAH SA (NASDAQ), CHUNLI MEDICAL (HKEx), INTERCURE LTD (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), PAVMED INC (NASDAQ), AXOGEN INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), HEARTCARE-B (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ZYNEX INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), BASECARE-B (HKEx), STEREOTAXIS INC (NYSE American), MISONIX INC (NASDAQ), NEUROPACE INC (NASDAQ), IRADIMED CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), CYTOSORBENTS CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACCELERATE DIAGNOSTICS INC (NASDAQ), ONCOCYTE CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SIENTRA INC (NASDAQ), CONFORMIS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), YESTAR HEALTH (HKEx), CVRX INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), QUOTIENT LTD (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), AROA BIOSURGERY LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), PW MEDTECH (HKEx), DARIOHEALTH CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), INVACARE CORP (NYSE), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SOMNOMED LIMITED (ASX), REPRO MEDSYSTEMS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CYCLOPHARM LIMITED (ASX), ALPHA PRO TECH (NYSE American), IMPEDIMED LIMITED (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), FONAR CORP (NASDAQ), IRIDEX CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), KELFRED (HKEx), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), BIOLASE INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), VINCENT MED (HKEx), SDI LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), LENSAR INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RGTBHD (Bursa), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), BIOMERICA INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), YUNNAN ENERGY (HKEx), AETHLON MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), NEOVASC INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), ADVENTA (Bursa), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), NOVA EYE MEDICAL LIMITED (ASX), LKL (Bursa), CARDIEX LTD (ASX), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), NUWELLIS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-7.14 %
10 Days --0.017
-11.56 %
20 Days --0.040
-23.53 %
Medium Term Return 3 Months --0.150
-53.57 %
6 Months --0.155
-54.39 %
1 Year --0.170
-56.67 %
Long Term Return 2 Years --0.130
-50.00 %
Annualised Return Annualised --
-29.29 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.130 - 0.400 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High -0.270 % Change From 1 Year High (%) -67.50
2 Years Range 0.130 - 0.885 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High -0.755 % Change From 2 Years High (%) -85.31
5 Years Range 0.130 - 0.885 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.755 % Change From 5 Years High (%) -85.31
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) -53.57 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Dec 2020 Part 1(4.03 MB)
Annual Report 2019 Dec 2019 Part 1(5.32 MB)
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 0.132 0.132 0.130 0.130 493,600 0.1316
16 Sep 2021 0.131 0.135 0.131 0.134 648,700 0.1334
15 Sep 2021 0.133 0.133 0.131 0.131 232,600 0.1317
14 Sep 2021 0.135 0.135 0.133 0.133 469,800 0.1340
13 Sep 2021 0.140 0.140 0.135 0.135 353,600 0.1378
10 Sep 2021 0.141 0.141 0.139 0.140 157,400 0.1399
09 Sep 2021 0.141 0.142 0.141 0.141 97,700 0.1412
08 Sep 2021 0.143 0.144 0.141 0.144 95,500 0.1424
07 Sep 2021 0.145 0.145 0.143 0.143 435,800 0.1438
06 Sep 2021 0.146 0.146 0.142 0.145 242,700 0.1439
03 Sep 2021 0.144 0.147 0.143 0.147 323,100 0.1443
02 Sep 2021 0.141 0.147 0.141 0.145 729,400 0.1433
01 Sep 2021 0.144 0.145 0.140 0.141 326,300 0.1421
31 Aug 2021 0.146 0.150 0.142 0.147 725,300 0.1446
30 Aug 2021 0.152 0.153 0.148 0.148 722,800 0.1499
27 Aug 2021 0.154 0.157 0.147 0.150 2,318,600 0.1516
26 Aug 2021 0.135 0.152 0.131 0.152 3,456,800 0.1425
25 Aug 2021 0.141 0.141 0.133 0.135 2,669,100 0.1354
24 Aug 2021 0.153 0.153 0.139 0.141 3,116,600 0.1451
23 Aug 2021 0.170 0.170 0.153 0.158 2,221,300 0.1579
20 Aug 2021 0.178 0.178 0.170 0.170 1,201,900 0.1721
19 Aug 2021 0.182 0.184 0.179 0.179 661,100 0.1800
Summary
Current 2 Weeks
(06 Sep 2021 to 17 Sep 2021)
0.146 0.146 0.130 0.130 3,227,400 -
Previous 2 Weeks
(23 Aug 2021 to 03 Sep 2021)
0.170 0.170 0.130 0.147 16,609,300 -
4 Weeks from
(23 Jul 2021 to 20 Aug 2021)
0.265 0.265 0.130 0.170 15,963,400 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.